Cargando…

Novel teatment options in early-stage non-small-cell lung cancer

Detalles Bibliográficos
Autor principal:	van Meerbeeck, Jan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041177/ https://www.ncbi.nlm.nih.gov/pubmed/26217139 http://dx.doi.org/10.1016/j.ejcsup.2013.07.037

Ejemplares similares

Surgical Extracts: Surgical Teatment of Goitre Hypertrophy of the Prostate — Rhinitis Œdematosa
por: Pilgrim, H. W.
Publicado: (1894)

Optimal approach for upfront resectable non-small-cell lung cancer
por: van Meerbeeck, Jan P.
Publicado: (2013)

Effects of long-term Teatment of Captopril and Enalapril on Rat Intestinal Angiotenisin Converting Enzyme Specific Activities
por: Song, In Sung, et al.
Publicado: (1994)

Therapeutic management options for stage III non-small cell lung cancer
por: Yoon, Stephanie M, et al.
Publicado: (2017)

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options
por: Petrella, Francesco, et al.
Publicado: (2023)

The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?
por: van Meerbeeck, Jan P., et al.
Publicado: (2013)

Recent developments in the treatment of small cell lung cancer
por: Hiddinga, Birgitta I., et al.
Publicado: (2021)

Novel Therapeutic Options for Small Cell Lung Cancer
por: Canova, Stefania, et al.
Publicado: (2023)

Knowing the Bad: Adverse Event–Informed, High-Risk, Early-Stage Non-Small Cell Lung Cancer Treatment Options
por: Phillips, Joseph D.
Publicado: (2022)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

Emerging Options for the Management of Non-Small Cell Lung Cancer
por: Binder, Daniel, et al.
Publicado: (2013)

Disparities in surgical treatment of early-stage non-small-cell lung cancer.
por: Polednak, A. P.
Publicado: (2001)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2012)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Therapy option for early-stage lung cancer in nonsurgical patients
por: Safi, Seyer, et al.
Publicado: (2022)

Clinical and Surgical-Pathological Staging in Early Non-Small Cell Lung Cancer
por: Koukis, Ioannis, et al.
Publicado: (2013)

Carbon Ion Therapy for Early-Stage Non-Small-Cell Lung Cancer
por: Demizu, Yusuke, et al.
Publicado: (2014)

Features of fatigue in patients with early-stage non-small cell lung cancer
por: Huang, Xianping, et al.
Publicado: (2015)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2017)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Multidisciplinary Management of Resectable Early-Stage Non–Small Cell Lung Cancer
por: Jacky, Jennifer, et al.
Publicado: (2022)

Adaptation criterion for segmentectomy in small‐sized early stage non‐small cell lung cancer
por: Motono, Nozomu, et al.
Publicado: (2022)

Initial Medical Attention on Patients with Early-Stage Non-Small Cell Lung Cancer
por: Chen, Xing, et al.
Publicado: (2012)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Staging non-small cell lung cancer*
por: Quint, Leslie Eisenbud
Publicado: (2007)

Impact of Sarcopenia on Early Postoperative Complications in Early-Stage Non–Small-Cell Lung Cancer
por: Lee, Jiyun, et al.
Publicado: (2020)

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
por: Geng, Qing, et al.
Publicado: (2014)

Lung cancer screening in Europe: where are we in 2021?
por: van Meerbeeck, Jan P., et al.
Publicado: (2021)

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine
por: Pons-Tostivint, Elvire, et al.
Publicado: (2022)

Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
por: Schwander, Bjoern, et al.
Publicado: (2012)

Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer
por: Li, Shan, et al.
Publicado: (2017)

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
por: Huang, Chien-Hung, et al.
Publicado: (2014)

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer
por: Wasp, Garrett T., et al.
Publicado: (2020)

Identifying candidate diagnostic markers for early stage of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l09e452ig2ecbosl6l73lc0ksi